Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.

MLA

Agostini, Simone, et al. “Serum MiR-34a-5p, MiR-103a-3p, and MiR-376a-3p as Possible Biomarkers of Conversion from Relapsing-Remitting to Secondary Progressive Multiple Sclerosis.” Neurobiology of Disease, vol. 200, Oct. 2024, p. 106648. EBSCOhost, https://doi.org/10.1016/j.nbd.2024.106648.

APA

Agostini, S., Mancuso, R., Citterio, L. A., Caputo, D., Oreni, L., Nuzzi, R., Pasanisi, M. B., Rovaris, M., & Clerici, M. (2024). Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis. Neurobiology of Disease, 200, 106648. https://doi.org/10.1016/j.nbd.2024.106648

Chicago

Agostini, Simone, Roberta Mancuso, Lorenzo Agostino Citterio, Domenico Caputo, Letizia Oreni, Riccardo Nuzzi, Maria Barbara Pasanisi, Marco Rovaris, and Mario Clerici. 2024. “Serum MiR-34a-5p, MiR-103a-3p, and MiR-376a-3p as Possible Biomarkers of Conversion from Relapsing-Remitting to Secondary Progressive Multiple Sclerosis.” Neurobiology of Disease 200 (October): 106648. doi:10.1016/j.nbd.2024.106648.